Psychedelic drugs are making a psychiatric comeback. After a lull of half a century, researchers are once again investigating the therapeutic benefits of psilocybin (‘magic mushrooms’) and LSD. There’s mounting evidence that psychedelic experiences can be genuinely transformative, especially for people suffering from intractable anxiety, depression and addiction. ‘It is simply unprecedented in psychiatry that a single dose of a medicine produces these kinds of dramatic and enduring results,’ Stephen Ross, the clinical director of the NYU Langone Center of Excellence on Addiction, told Scientific American in 2016. To read the full article click here.
Dual Diagnosis: Free Certified eLearning
June 10, 2019
Cannabis-Gateway Revisited Special
May 20, 2018
Speaking at Cornwall & Devon PCC Conference on Dual Diagnosis Treatment Systems